Point-of-Care (POC) Immunoassay Devices Market Size, Sales, Average Price and Trends Analysis, till 2032

Point-of-Care (POC) Immunoassay Devices Market Size is estimated to be $12500 million in 2024 and is expected to grow at an average yearly rate of around 6% during the timeframe (2025-2032).

Monitor Country-wise Point-of-Care (POC) Immunoassay Devices Sales and Demand with Our Comprehensive Point-of-Care (POC) Immunoassay Devices Sales Database

Gain in-depth insights into the Point-of-Care (POC) Immunoassay Devices Sales landscape across United States, Germany, France, UK and 20+ countries with our specialized Point-of-Care (POC) Immunoassay Devices Sales Database. Stay ahead in the market by tracking country-wise Point-of-Care (POC) Immunoassay Devices Sales, identifying key manufacturers.

Extensive Point-of-Care (POC) Immunoassay Devices Sales database covering United States, Germany, France, UK and 20+ countries worldwide, Point-of-Care (POC) Immunoassay Devices Sales trends

Point-of-Care (POC) Immunoassay Devices market revenue tracker by country: United States, Germany, France, UK and 20+ countries worldwide

Stay Updated with Point-of-Care (POC) Immunoassay Devices Sales Trends

Track real-time Point-of-Care (POC) Immunoassay Devices prices, analyze Point-of-Care (POC) Immunoassay Devices price charts, and stay informed about sales trends across 20+ countries. Our interactive dashboards and trackers ensure complete transparency and up-to-date market intelligence.

The research and analytics firm Datavagyanik released the updated version of its report on "Point-of-Care (POC) Immunoassay Devices Market - Detailed Analysis, Business Opportunities and Forecasts".

Request sample at https://datavagyanik.com/reports/point-of-care-poc-immunoassay-devices-market/



Point-of-Care (POC) Immunoassay Devices sales trend in 2024 vs 2025

The global market for Point-of-Care (POC) immunoassay devices demonstrated notable growth in 2024 and is poised to continue its upward trajectory into 2025. This expansion is driven by several key factors, including advancements in diagnostic technology, increased demand for rapid testing solutions, and a growing emphasis on decentralized healthcare.

In 2024, the POC immunoassay devices market was valued at approximately USD 27.43 billion and is expected to reach USD 29.21 billion by 2025, reflecting a compound annual growth rate (CAGR) of 6.5% during this period. This growth is attributed to the rising prevalence of chronic diseases, the need for timely diagnostics, and the shift towards home-based and outpatient testing solutions.

Technological innovations have played a significant role in this market expansion. The integration of microfluidics, biosensors, and smartphone connectivity into POC devices has enhanced their accuracy, speed, and user-friendliness. These advancements have made it possible to conduct complex immunoassays outside traditional laboratory settings, thereby broadening the accessibility of diagnostic testing.

The COVID-19 pandemic underscored the importance of rapid diagnostic tools, leading to increased adoption of POC immunoassay devices. While the immediate demand for COVID-19 testing has stabilized, the infrastructure and awareness developed during the pandemic have paved the way for sustained interest in POC diagnostics for other infectious diseases, cardiovascular conditions, and metabolic disorders.

Healthcare systems worldwide are increasingly focusing on decentralized care models to improve patient outcomes and reduce costs. POC immunoassay devices align with this shift by enabling on-site testing, which facilitates quicker clinical decision-making and reduces the need for centralized laboratory services. This trend is particularly evident in emergency departments, urgent care centers, and remote healthcare facilities.

Request for customization https://datavagyanik.com/reports/point-of-care-poc-immunoassay-devices-market/



Point-of-Care (POC) Immunoassay Devices Market Definition

Point-of-care (POC) immunoassay devices refer to diagnostic tools designed to perform immunoassays at or near the site of patient care, allowing for immediate results without the need for laboratory analysis. These devices enable healthcare providers to conduct tests rapidly and efficiently, often within minutes, offering real-time results that aid in decision-making during patient care.

Immunoassays are a type of diagnostic test that detect specific proteins, antibodies, hormones, or other substances within a patient's sample, such as blood, saliva, or urine. They are commonly used to diagnose a wide range of conditions, including infectious diseases, cardiovascular issues, metabolic disorders, and even cancers. POC immunoassay devices offer the advantage of eliminating the need for central laboratory infrastructure, making testing faster, more accessible, and often more affordable.

These devices are typically compact, user-friendly, and designed to be operated by healthcare professionals with minimal training. They often incorporate technologies such as lateral flow assays, microfluidics, or electrochemical sensors to deliver accurate and reliable results. The ability to conduct immunoassays directly at the point of care significantly reduces the turnaround time for results, allowing clinicians to make informed decisions more quickly. This is particularly beneficial in emergency settings, urgent care facilities, and rural or remote areas where access to centralized labs may be limited.

One of the main driving forces behind the increasing adoption of POC immunoassay devices is the demand for faster diagnostics. In many medical scenarios, the ability to diagnose a condition quickly can have a profound impact on patient outcomes. For example, in emergency medicine, rapid identification of infectious agents, cardiac markers, or coagulation factors can enable immediate treatment, improving the chances of a positive outcome. Similarly, in chronic disease management, POC immunoassay devices enable continuous monitoring and more timely interventions.

Furthermore, the growing trend toward personalized medicine has increased the need for diagnostic tests that can be tailored to individual patients. POC immunoassay devices are able to support this by offering testing in a variety of healthcare settings, including clinics, doctors' offices, and even at home. With advancements in technology, many of these devices are now capable of connecting to smartphones or cloud platforms, allowing for easier data sharing and integration into patient health records.

The market for POC immunoassay devices has also been influenced by the increasing demand for home healthcare solutions, as patients seek more convenience and autonomy in managing their health. This trend has been particularly accelerated by the COVID-19 pandemic, which emphasized the need for decentralized testing options. Today, patients are more inclined to use POC immunoassay devices for conditions such as glucose monitoring, pregnancy testing, and even COVID-19 or flu diagnostics.



Important target segments driving the demand for Point-of-Care (POC) Immunoassay Devices Market

The demand for Point-of-Care (POC) immunoassay devices is driven by several target segments, each contributing significantly to the growth of the market. These segments encompass various healthcare sectors and patient populations that require rapid, accurate, and easily accessible diagnostic solutions. The most important target segments influencing the demand for POC immunoassay devices include hospitals and emergency care settings, outpatient clinics, home healthcare, infectious disease diagnostics, chronic disease management, and remote or underserved populations.

Hospitals and Emergency Care Settings:
Hospitals, particularly emergency departments (EDs), represent a major target segment for POC immunoassay devices. The ability to quickly diagnose a wide range of conditions, such as infections, cardiac events, and metabolic disorders, is crucial for ensuring timely and effective treatment. In emergency situations, every minute counts, and the speed of POC immunoassay devices helps clinicians make fast decisions about patient care. This capability enhances patient outcomes by providing immediate test results for critical markers like troponin (for heart attacks) or D-dimer (for clotting disorders), which are essential in emergency scenarios.

Outpatient Clinics and Urgent Care Centers:
Outpatient clinics and urgent care centers are growing rapidly as patients increasingly seek convenient and cost-effective healthcare solutions. These centers need reliable and quick diagnostics to treat a variety of conditions, ranging from infections like influenza or strep throat to chronic conditions such as diabetes. POC immunoassay devices meet this demand by delivering fast, accurate results that help healthcare providers make informed treatment decisions on-site. This reduces wait times for patients, improves clinical workflows, and minimizes the need for follow-up laboratory visits.

Home Healthcare:
Home healthcare is a burgeoning segment within the healthcare industry, driven by the increasing preference for patients to receive care at home rather than in hospitals or clinics. POC immunoassay devices tailored for home use allow patients to manage their health conditions independently. Examples include glucose meters for diabetes management or home pregnancy tests. As patients continue to seek greater autonomy in managing chronic conditions, the demand for user-friendly, accurate, and safe POC devices for home use grows. These devices empower patients to track their health status and make timely adjustments to their treatments without having to visit healthcare facilities regularly.

Infectious Disease Diagnostics:
The COVID-19 pandemic highlighted the need for rapid, accurate, and accessible testing solutions for infectious diseases. This segment remains one of the most critical drivers of demand for POC immunoassay devices, particularly for diagnosing conditions like influenza, respiratory infections, sexually transmitted infections (STIs), and more. The ongoing need for fast, portable, and easily administered tests in various settings-including travel hubs, workplaces, and public health facilities-continues to propel the growth of the POC immunoassay market. POC devices help mitigate the spread of infections by providing on-the-spot results, enabling quicker isolation or treatment of infected individuals.

Chronic Disease Management:
Chronic diseases, including diabetes, cardiovascular diseases, and kidney disorders, require continuous monitoring to manage effectively. POC immunoassay devices are essential tools for patients who need regular monitoring of biomarkers such as glucose levels, cholesterol, or kidney function. By enabling frequent testing outside of a clinical setting, these devices help patients manage their conditions proactively, reducing the need for frequent doctor visits and promoting better long-term health outcomes.

Remote and Underserved Populations:
Finally, underserved and remote populations in rural or resource-poor areas represent an important target market for POC immunoassay devices. In regions where access to centralized labs and healthcare facilities is limited, POC devices provide a vital solution for diagnosing a wide range of conditions without the need for specialized infrastructure. These devices improve access to healthcare in areas that would otherwise be underserved, contributing to the global effort to address healthcare disparities.



Key Players in Point-of-Care (POC) Immunoassay Devices, Market Share: United States and global market

The Point-of-Care (POC) immunoassay devices market is characterized by the presence of several key players that dominate both the United States and the global market. These companies are at the forefront of providing rapid, accurate diagnostic solutions that enable healthcare providers to perform tests directly at or near the site of patient care. The market is growing due to technological advancements, the increasing need for quick diagnoses, and the shift toward decentralized healthcare models. The key players in the POC immunoassay devices market are actively involved in research and development, product innovation, and strategic partnerships, which significantly contribute to their market share.

In the United States, several major players are driving the POC immunoassay market. Abbott Laboratories is a leading player, offering a wide range of POC immunoassay devices, including the i-STAT and ARCHITECT systems. These devices are commonly used in emergency care settings and hospitals for quick and accurate test results, enabling immediate treatment decisions. Another major player in the U.S. market is Becton, Dickinson and Company (BD), known for its BD VeritorTM Plus System, which provides fast and reliable testing for infectious diseases, including influenza and COVID-19. Siemens Healthineers is also a key player, offering solutions like the Atellica® series, which are designed for use in point-of-care testing environments and are known for their efficiency and high throughput.

Other significant players in the U.S. market include Thermo Fisher Scientific, which provides the ImmunoCAP® system used for allergy testing, and QuidelOrtho Corporation, known for its Sofia® and QuickVue® platforms that offer rapid diagnostic results for a variety of conditions. Additionally, Bio-Rad Laboratories, through its BioPlex® systems, delivers multiplex testing capabilities that are gaining popularity in clinical settings for a broad range of diseases.

Globally, companies such as F. Hoffmann-La Roche Ltd, Danaher Corporation, and bioMérieux SA play a significant role in shaping the POC immunoassay devices market. Roche, a leader in global diagnostics, offers systems like the Elecsys® and cobas® series, which are widely used for various immunoassay applications, including infectious diseases and oncology. Danaher Corporation, through its subsidiaries like Beckman Coulter and Cepheid, provides diagnostic platforms that are used across the world for POC testing, particularly in clinical and hospital settings. BioMérieux, with its VIDAS® and miniVIDAS® systems, is a prominent player in the global market, offering reliable solutions for infectious disease testing.

The global market also benefits from the contributions of QuidelOrtho Corporation, which has expanded its presence with rapid diagnostic devices such as the Sofia® system, used in many regions for point-of-care diagnostics. Thermo Fisher Scientific, through its comprehensive portfolio, remains a strong player in international markets, offering solutions like ImmunoCAP® for allergy testing. Additionally, DiaSorin, an Italian biotechnology company, provides diagnostic solutions through its LIAISON® systems, which cater to a wide range of immunoassay applications.

Key Questions Answered in the Point-of-Care (POC) Immunoassay Devices market report:

What is the total global and United States Point-of-Care (POC) Immunoassay Devices Sales volume, and how has it changed over the past five years?

What is Point-of-Care (POC) Immunoassay Devices price trend, what has been the historical prices in United States and other countries?

What will be the Point-of-Care (POC) Immunoassay Devices price trend in 2025?

United States Point-of-Care (POC) Immunoassay Devices Sales, and what factors contribute to their dominance in the market?

How does Point-of-Care (POC) Immunoassay Devices Sales vary across key manufacturers, and what expansions have been observed recently?

What is the revenue generated from Point-of-Care (POC) Immunoassay Devices Sales, and how does it compare to previous years, in the United States and other parts of the world?

Which industries drive the highest demand for Point-of-Care (POC) Immunoassay Devices, and how is this demand expected to evolve in the next five years?

What are the major challenges impacting Point-of-Care (POC) Immunoassay Devices Sales and supply chain operations across key markets?

How do government policies, environmental regulations, and trade restrictions affect Point-of-Care (POC) Immunoassay Devices Sales and market dynamics?

Related Studies:

Carbon Fiber Knee Braces Market
https://datavagyanik.com/reports/carbon-fiber-knee-braces-market/

Remote Magnetic Navigation (RMN) Systems Market
https://datavagyanik.com/reports/remote-magnetic-navigation-rmn-systems-market/

Electrophysiology Recording Systems Market
https://datavagyanik.com/reports/electrophysiology-recording-systems-market/

Multiplex Immunoassay System Market
https://datavagyanik.com/reports/multiplex-immunoassay-system-market/

Fully Automated Immunoassay Analyzers Market
https://datavagyanik.com/reports/fully-automated-immunoassay-analyzers-market/

IT Park, Dehradun, UK

Datavagyanik is a business intelligence firm with clients worldwide. We provide the right knowledge and advisory to business organizations and help them to grow and excel. We specialize in areas such as Pharmaceutical, Healthcare, Manufacturing, Consumer Goods, Materials & Chemicals and others. We specialize in market sizing, forecasting, supply chain analysis, supplier intelligence, import-export insights, market trend analysis and competitive intelligence.

Contact us:

Peter (Sales Head)
Phone: +1-330-440-0311
Website: https://datavagyanik.com/
Linkedin: https://www.linkedin.com/company/datavagyanik-business-intelligence-solutions/
Email: sales@datavagyanik.com

This release was published on openPR.